Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 5/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ALPG | P10696 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 6/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | GLA | P06280 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.53 |
| ▸ | GSK3B | P49841 | 1/20 | 0.53 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6910150 | 0.88 | TSHR (0.53) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL10538765 | 0.85 | LMNA (0.51) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL20683078 | 0.82 | TSHR (0.47) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL18250747 | 0.82 | ALDH1A1 (0.58) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL1980314 | 0.80 | HSD17B10 (0.57) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL2607467 | 0.79 | ALDH1A1 (0.72) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL18250744 | 0.79 | HTT (0.55) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL18250699 | 0.79 | TSHR (0.51) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL1128688 | 0.78 | SMN1; SMN2 (0.60) | HSD17B10ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL1104440 | 0.78 | HSD17B10 (0.56) | HSD17B10ALDH1A1KDM4EHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378232-B2 | Cyclin dependent kinase inhibitors | PFIZER INC. (US) | 2025-08-05 | — | — | US | disclosed |
| CN-119707834-A | Preparation method of arbeli and intermediate thereof | 常州制药厂有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20230295180-A1 | PROTEIN DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230200205-A1 | Emitting Compound and Organic Light Emitting Device Including the Same | LG DISPLAY CO., LTD. (KR) | 2023-06-22 | — | — | US | disclosed |
| US-20230189642-A1 | Emitting Compound and Organic Light Emitting Device Including the Same | LG DISPLAY CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| EP-4157847-A1 | DRUG-LIKE MOLECULES AND METHODS FOR THE THERAPEUTIC TARGETING OF VIRAL RNA STRUCTURES | University of Washington (US) | 2023-04-05 | — | — | EP | disclosed |
| US-20220089580-A1 | CYCLIN DEPENDENT KINASE INHIBITORS | PFIZER INC. (US) | 2022-03-24 | — | — | US | disclosed |
| US-20220000883-A1 | PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | EMORY UNIVERSITY | 2022-01-06 | — | — | US | disclosed |
| US-11203613-B2 | Peptidomimetic proteasome inhibitors | CORNELL UNIVERSITY | 2021-12-21 | — | — | US | disclosed |
| US-20210284805-A1 | DESIGN OF LIGAND ATTACHMENT CHEMISTRY FOR HIGH CONDUCTIVITY POLYMER ELECTROLYTES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-09-16 | — | — | US | disclosed |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-26 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-7589204-B2 | Indane compounds as CCR5 antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2009-09-15 | — | — | US | disclosed |
| US-20090187021-A1 | INDANE COMPOUNDS AS CCR5 ANTAGONISTS | YOUNGMAN MICHAEL | 2009-07-23 | — | — | US | disclosed |
| US-7531661-B2 | Indane compounds as CCR5 antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-12 | — | — | US | disclosed |
| US-7531661-B2 | Indane compounds as CCR5 antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2009-05-12 | — | — | US | disclosed |
| EP-2040666-A2 | BENZIMIDAZOLES AS COOLING COMPOUNDS | Givaudan SA (CH) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008006236-A2 | BENZIMIDAZOLES AS COOLING COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-17 | — | — | WO | disclosed |
| US-20070015773-A1 | Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders | AMGEN INC. | 2007-01-18 | — | — | US | disclosed |
| US-6875765-B2 | Arylsulfonamide ethers, and methods of use thereof | WARNER-LAMBERT COMPANY (US) | 2005-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000883-A1 | PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO | PTGER2, PTGES2, PTGER1 | HSD17B10 3141/4885ALDH1A1 1095/4885KDM4E 3087/4885 |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, ORMDL3, CHRM2 | HSD17B10 1775/4885ALDH1A1 818/4885KDM4E 3872/4885 |
| US-20230295180-A1 | PROTEIN DEGRADERS AND USES THEREOF | MDM2, CUL1, PSMG3 | HSD17B10 2131/4885ALDH1A1 3843/4885KDM4E 935/4885 |
| US-11203613-B2 | Peptidomimetic proteasome inhibitors | PSMB1, PSMB3, PSMB11 | HSD17B10 4401/4885ALDH1A1 4639/4885KDM4E 1197/4885 |
| US-12378232-B2 | Cyclin dependent kinase inhibitors | CCNY, CCNI, CCNK | HSD17B10 4271/4885ALDH1A1 4211/4885KDM4E 715/4885 |
| US-20070015773-A1 | Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders | CCR1, MSR1, CCR2 | HSD17B10 2108/4885ALDH1A1 742/4885KDM4E 3102/4885 |
| US-20220089580-A1 | CYCLIN DEPENDENT KINASE INHIBITORS | CCNY, CCNI, CCNK | HSD17B10 4271/4885ALDH1A1 4211/4885KDM4E 715/4885 |
| US-20090187021-A1 | INDANE COMPOUNDS AS CCR5 ANTAGONISTS | CCR5, CCL5, IDO1 | HSD17B10 2373/4885ALDH1A1 2472/4885KDM4E 4383/4885 |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | OCIAD1, OCIAD2, ORMDL3 | HSD17B10 2120/4885ALDH1A1 498/4885KDM4E 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.